Plant Health Care - Director Shareholding

Plant Health Care

27/06/2023 13:08

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230627:nRSa0846Ea&default-theme=true

RNS Number : 0846E  Plant Health Care PLC  27 June 2023

27 June 2023

Plant Health Care plc

("Plant Health Care", or the "Company")

Director Shareholding

Plant Health Care plc, a leading provider of novel patent-protected biological
products to global agricultural markets, confirms that, following his
participation in the Fundraising announced on 23 June 2023, James
Ede-Golightly, Non-Executive Director, has a beneficial interest in 936,096*
Ordinary Shares in the Company, representing approximately 0.27 per cent of
enlarged issued share capital.

For further information, please contact:

 Plant Health Care plc                   Tel: +1 919 926 1600
 Jeff Tweedy, CEO
 Jeff Hovey, CFO

 Cenkos Securities plc                   Tel: +44 (0) 20 7391 8900
 Neil McDonald
 Pete Lynch

 SEC Newgate - Financial Communications  Tel: +44 (0) 7540 106 366
 Robin Tozer
 George Esmond
 Harry Handyside

 

*                     The Company's announcement on 23
June 2023 incorrectly notified that Mr Ede-Golightly had a total interest in
310,488 Ordinary Shares, representing 0.09 per cent of the enlarged issued
share capital.

About Plant Health Care plc

Plant Health Care offers products to improve the health, vigour and yield of
major field crops such as corn, soybeans, potatoes and rice, as well as
specialty crops such as fruits and vegetables. We operate globally through
subsidiaries, distributors and supply agreements with major industry partners.
Our innovative, patent-protected biological products help growers to protect
their crops from stress and diseases, and to produce higher quality fruit and
vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com (http://www.planthealthcare.com/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHPPUMUQUPWGPM